期刊文献+

替罗非班在ST段抬高心肌梗死急诊PCI疗效观察 被引量:5

Observation of Pre-Angiography Use of Tirofiban in Patients with Acute ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
原文传递
导出
摘要 目的探讨在急性ST段抬高心肌梗死(STEMI)患者早期应用替罗非班对行经皮冠脉介入治疗术前、术中相关血管(IRA)再通率的疗效,术后心血管事件的发生率及PCI术后出血等并发症的发生率。方法选择2009年2月-2010年2月共85例在医院行急诊冠状动脉造影+经皮冠状动脉腔内介入术(CAG+PCI)的患者,其中男性52例,女性33例,将患者随机分为两组,A组为替罗非班组:共45例,于行PCI术前至少40 min使用替罗非班;B组为常规治疗组:共40例,术前未使用替罗非班,常规内科常规、抗凝、抗血小板等治疗,通过观察患者于冠脉造影术中显示病变相关血管(IRA)前向血流、PCI术中慢血流或无复流现象、术后出血并发症及近期心血管事件发生率,采用SPSS统计软件包,采用χ2检验。结果所有患者均成功行PCI术,两组患者行急诊冠脉造影结果显示病变相关血管(IRA)远端血流TIMI 2~3级出现率,A组患者明显高于B组患者,差异存在统计学意义(P<0.05)。术中出现慢血流或无复流现象和术中及术后两组患者出血及近期严重心血管事件发生率两者差异均无统计学意义。结论急性ST段抬高心肌梗死于行急诊PCI术前早期使用替罗非班,能有效促进闭塞血管术前血流的再通,改善相关血管的前向血流,有助于提高急诊PCI的判断及成功率,而出血等并发症及近期心血管事件并没有增加。 Objective To study the efficacy of recanalization rate of early tirofiban use in patients with acute ST segment elevation myocardial infarction pre-operative and operative, and the incidence of complication such as post-operative bleeding and cardial events post-operative. Methods 85 patients who received the emergent CAG and PCI in our hospital from February 2009 to February 2010 were randomly divided into 2 groups :tirofiban group(45 cases) ,which was used Tirofiban at least 40 min before PCI,conventional treatment group (40 cases) ,which was treated with anti-coagulation and anti-platelet treatment. In order to observe the efficacy, the IRA forward flow, slow flow and no-reflow, the complications after-PCI were observed and analyzed with the SPSS statistical package. Results All the PCI was successful. IRA and the occurrence rate of flow TIMI 2 N 3 in tirofiban group were significantly higher that those in conventional treatment group. The difference of IRA forward flow, slow flow and no-reflow, the complications after-PCI between the two groups were not significant. Conclusion Early tirofiban can efficiently promote the recanalization rate of no-operative occlusive vascular, improve the forward flow of IRA, promote the success rate and judgement of emergent. Cases with acute ST segment elevation cardial infarction before emergent PCI, and the complications of bleeding and recent cardial events remained the same.
出处 《中华全科医学》 2011年第4期548-549,共2页 Chinese Journal of General Practice
关键词 替罗非班 经皮冠状动脉腔内介入术 ST段抬高急性心肌梗死 Tirofiban Percutaneous comary intervention ( PCI ) ST-elevation myocardial infarction
  • 相关文献

参考文献10

  • 1叶任高,陆再英.内科学[M].6版.北京:人民卫生出版社,2005.948-987.
  • 2夏新社,杨丽,张海水.溶栓疗法治疗急性心肌梗死38例临床报告[J].实用全科医学,2006,4(4):442-442. 被引量:3
  • 3邱雪梅,辛彩凤,荆丽敏,牛莎莎,韩晶茹,何平.急性冠状动脉综合征患者应用盐酸替罗非班的观察与护理[J].武警医学,2008,19(6):569-570. 被引量:12
  • 4高润霖 等.急性心肌梗塞直接PCI术治疗指南.中华心血管病杂志,2002,30(12):804-807.
  • 5Tanaka A, Kawarabayashi T, Nishibori Y, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction[ J]. Circulation ,2002,105:2148-2152.
  • 6沈杰,沈卫峰.替罗非班在急性冠脉综合征介入治疗中的应用[J].国际心血管病杂志,2006,33(3):156-159. 被引量:72
  • 7中华心血管病分会.首届全围介人心脏病学年会纪要.中华心血管病杂志,2002,:385-385.
  • 8APetronion AS, Royal D, Musumeci G, et al. Effect of abciximab on mi- crovascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty[ J]. Euro Heart Journal ,2003,24:67-76.
  • 9Brown DL. Deaths associated with platelet glycoprotein llb/IIIa inhibitor treatment [ J ]. Heart, 2003,89 : 535-553.
  • 10Mukheryee D, Moliterno DJ. Achieving tissue level perfusion in the wetting of acute myocardial infarction [ J ]. Am J Cardiol, 2002,85 : 39c-46c.

二级参考文献27

  • 1王志坚,林文华,刘菁晶,史宏岩,任自文.盐酸替罗非班治疗亚急性支架内血栓二例[J].中华心血管病杂志,2006,34(1):74-75. 被引量:8
  • 2李洪稳,周继新,尚爱英,王海英,王玉刚,元柏民.心脏介入术后并发急性肺血栓栓塞的预防和护理[J].中国实用护理杂志(中旬版),2006,22(3):23-23. 被引量:21
  • 3宋玉娥,王琳,李芳,龚培力,王朝晖,党瑜华.盐酸替罗非班对急性冠状动脉综合征的疗效和安全性评价[J].临床心血管病杂志,2006,22(4):220-222. 被引量:71
  • 4[1]Elmouchi DA,Bates ER.Platelet glycoprotein Ⅱb/Ⅲa inhibitor therapy in non-ST segment elevation acute coronary syndromes[J].Minerva Cardioangiol,2003,51 (5):547-560.
  • 5[2]Valgimigli M,Percoco G,Malagutti P,et al.Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction:a randomized trial[J].JAMA,2005,293 (17):2109-2117.
  • 6[3]Heitzer,T Ollmann,I Koke,K et al.Platelet Glycoprotein Ⅱb/Ⅲa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease[J].Circulation,2003,108 (5):536-541.
  • 7[4]Warnholtz A,Ostad MA,Heitzer T,et al.Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease[J].Am J Cardiol,2005,95 (1):20-23
  • 8[5]De Luca G,Smit JJ,Ernst N,et al.Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction[J].Thromb Haemost,2005,93 (5):820-823.
  • 9[6]Martinez-Rios MA,Rosas M,Gonzalez H,et al.Comparison of reperfusion regimens with or without tirofiban in STelevation acute myocardial infarction[J].Am J Cardiol,2004,93 (3):280-287.
  • 10[7]Lavi S,Gruberg L,Kapeliovich M,et al.The impact of GP Ⅱb/Ⅲa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients[J].J Invasive Cardiol,2005,17 (6):296-299.

共引文献416

同被引文献58

  • 1李芳,余素琴,杜艳华,王峥,叶恒泰.氯吡格雷在急性冠状动脉综合征中的抗炎作用[J].临床心血管病杂志,2006,22(12):716-718. 被引量:20
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.不稳定性心绞痛和非ST段抬高心肌梗死诊断和治疗建议.中华心血管病杂志,2007,35(4):296-297.
  • 3颜红兵,马长生,霍勇,等.美国冠心病诊断与治疗指南[M].2版.北京:中国环境出版社.2006:215-217.
  • 4谢晓春,刘胜林,杨军珂,李元风,赵贵峰,胡丽华,白玉蓉,丁力平.替罗非班对急性心肌梗死急诊介入治疗后微血管功能不全和早期左心室重构的影响[J].中国循环杂志,2007,22(4):267-270. 被引量:13
  • 5洪涛.冠状动脉TIMI血流分级.中国介入心脏病学杂志,2003,11:154.
  • 6Jaitner J,Stegherr J,Morath T,et al. Stability of the high on treatment platelet reactivity phenotype over time in clopidogrel treated patients [J]. Thromb Haemost ,2011,105 (1) : 107-112.
  • 7Patrono C, Coller B, Fitzgerald GA,et al. Platelet-active drugs: the ralationships among dose,effectiveness, and side effects : the seventh ACCP conference on antithrombotic and thrombolytic therapy [ J ]. Chest,2004,126(3 Suppl) :234S-264S.
  • 8Altman R,Luciardi HL,Muntaner J,et al. The antithrombotic profile of asipirin. Aspirin resistance, or simply failure? [J]. Thromb J, 2004,2(1):1.
  • 9Keeley EC,Boura JA,Grines CL.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative revicw of 23 randomised trials.Lancet,2003,361:13-20.
  • 10Zijlstra F,Hoorntje JC,De Boer M J,et al.Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.N Engl J Med,1999,341:1413-1419.

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部